Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable c...
Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
We aimed to determine microbial signature linked with lung cancer (LC) diagnosis and to define taxa linked with durable clinical benefit (DCB) of advanced LC patients. Stool samples for microbial 16S amplicon sequencing and clinical data were collected from 75 LC patients (50 of which were treated with checkpoint inhibitors) and 31 matched healthy...
Alternative Titles
Full title
Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ea2d9eaa9f9f4024bc7931e585ab96f2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ea2d9eaa9f9f4024bc7931e585ab96f2
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-023-29136-4
